Selamectin
CAS number： 220119-17-5
Molecular formula： C43H63NO11
molecular weight： 769.9604
Chemical structure：
Producers shown on SFDA
(Record date:05/11/2021）
Producer | Documents | GMP Valid till(based on SFDA) |
| Livzon New North River Pharmaceutical Co., Ltd. | GMP | Valid till January 2026 |
| Hisun Pharmaceutical (Nantong) Co., Ltd. | GMP | Valid till April 2025 |
Producers shown on EP
(Quoted from EP website；record date:05/11/2021）
| Substance | Certificate Holder | Certificate Number | Issue Date | Status | End date | Type |
| Selamectin for veterinary use | JIANGSU WILLING BIO-TECH CO., LTD. Huaian City CN | R0-CEP 2017-124 - Rev 00 | 12/10/2018 | Valid | / | Chemical |
| Selamectin for veterinary use | ZHEJIANG JINHUA CONBA BIO-PHARM. CO., LTD. Jinhua City CN | R0-CEP 2018-272 - Rev 01 | 13/01/2021 | Valid | / | Chemical |
| Selamectin for veterinary use | LIVZON NEW NORTH RIVER PHARMACEUTICAL CO., LTD. Qingyuan City CN | R0-CEP 2017-070 - Rev 01 | 16/02/2021 | Valid | / | Chemical |
Producer:Livzon New North River Pharmaceutical Co., Ltd., established in 1990, covers an area of 150000 square meters and a construction area of 50000 square meters. It mainly produces pharmaceutical raw materials and pharmaceutical intermediates. Its products are widely used in cardio cerebrovascular, organ transplantation, anti infection, hypoglycemic and other drugs.
New North River Pharmaceutical has a perfect quality assurance system. Two varieties have passed the on-site inspection of FDA, seven varieties have obtained the DMF number of the United States, one product has obtained the EU CEP certificate, and all API production lines have passed the domestic GMP certification.
Staff size:600-699 people
Registered capital:RMB 239 million 887 thousand and 700
Website: http://www.livzon-nnr.com
Producer:Hisun Pharmaceutical (Nantong) Co., Ltd. is a pharmaceutical base of Zhejiang Hisun Pharmaceutical Co., Ltd.
Hisun has more than 40 varieties officially certified by FDA of the United States, EDQM of the European Union, TGA of Australia and KFDA of Korea. The R & D fields of the company cover chemical synthesis, microbial fermentation, biotechnology, natural plant extraction and preparation development, The product treatment field involves anti-tumor, cardiovascular system, anti infection, anti parasite, endocrine regulation, immunosuppression, antidepressant, etc.
Staff size:300-399 people
Registered capital:RMB 1010 million
Website: http://www.hisunpharmnt.com
For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978
Tel: Cell/WhatsApp/WeChat: +86 18402846978
Email: paulzhang@yinuopharmchem.com
SKYPE